Conference
Annual Corporate Compliance and Transparency in the Pharmaceutical Industry 2015
Medicine · Pharmaceuticals
Key numbers
- Editions on record
- 2first in 2015
About Annual Corporate Compliance and Transparency in the Pharmaceutical Industry
What Will You Hear About
EFPIA disclosure requirements
Change Management- How to prepare your team for transparency
Defining a transparency framework: Local vs. Regional vs. Global
The human side of compliance: communication, training and talent management
How to prevent corruption in your organisation
The challenges in emerging markets and their impact in Europe
Review tools and techniques for assessing risk posed by third parties
Key Questions
Disclosure requirements – what is the actual impact on the industry?
How does the medical community perceive the code?
What are the do's and don'ts when implementing local, regional, or global approaches to transparency?
What new ways of cooperation have emerged between industry and HCPs?
What makes a good compliance officer?
Third Parties' Risk – what are the strategies and tools available?
What are the warning signs in the cooperation with third parties?
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2017 | 22–23 Feb 2017 | Eurostars Berlin Hotel Berlin, Germany | — | — |
| 2015 | 25–26 Feb 2015 | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.